BRAF and central nervous system cancer: Sequencing analyses revealed that KNS1451 did not harbor glioma-related driver mutations, such as IDH1/2, BRAF, and H3F3A, except for the TERT promoter C250T mutation detected by Sanger sequencing (Supplementary Fig. 2a).